Sahlholm Kristoffer, Zeberg Hugo, Nilsson Johanna, Ögren Sven Ove, Fuxe Kjell, Århem Peter
Department of Neuroscience, Karolinska Institutet, Retzius väg 8, SE-171 77 Stockholm, Sweden.
Department of Neuroscience, Karolinska Institutet, Retzius väg 8, SE-171 77 Stockholm, Sweden.
Eur Neuropsychopharmacol. 2016 Mar;26(3):467-76. doi: 10.1016/j.euroneuro.2016.01.001. Epub 2016 Jan 14.
Newer, "atypical" antipsychotics carry a lower risk of motor side-effects than older, "typical" compounds. It has been proposed that a ~100-fold faster dissociation from the dopamine D2 receptor (D2R) distinguishes atypical from typical antipsychotics. Furthermore, differing antipsychotic D2R affinities have been suggested to reflect differences in dissociation rate constants (koff), while association rate constants (kon) were assumed to be similar. However, it was recently demonstrated that lipophilic accumulation of ligand in the cell interior and/or membrane can cause underestimation of koff, and as high-affinity D2R antagonists are frequently lipophilic, this may have been a confounding factor in previous studies. In the present work, a functional electrophysiology assay was used to measure the recovery of dopamine-mediated D2R responsivity from antipsychotic antagonism, using elevated concentrations of dopamine to prevent the potential bias of re-binding of lipophilic ligands. The variability of antipsychotic kon was also reexamined, capitalizing on the temporal resolution of the assay. kon was estimated from the experimental recordings using a simple mathematical model assumed to describe the binding process. The time course of recovery from haloperidol (typical antipsychotic) was only 6.4- to 2.5-fold slower than that of the atypical antipsychotics, amisulpride, clozapine, and quetiapine, while antipsychotic kons were found to vary more widely than previously suggested. Finally, affinities calculated using our kon and koff estimates correlated well with functional potency and with affinities reported from radioligand binding studies. In light of these findings, it appears unlikely that typical and atypical antipsychotics are primarily distinguished by their D2R binding kinetics.
新型的“非典型”抗精神病药物比旧的“典型”化合物产生运动副作用的风险更低。有人提出,与多巴胺D2受体(D2R)的解离速度快约100倍是区分非典型和典型抗精神病药物的特征。此外,不同抗精神病药物对D2R的亲和力差异被认为反映了解离速率常数(koff)的不同,而结合速率常数(kon)则被假定相似。然而,最近有研究表明,配体在细胞内部和/或膜中的脂溶性积累会导致koff被低估,而且由于高亲和力的D2R拮抗剂通常具有脂溶性,这可能是先前研究中的一个混杂因素。在本研究中,使用了一种功能性电生理测定法来测量多巴胺介导的D2R反应性从抗精神病药物拮抗作用中的恢复情况,通过使用升高的多巴胺浓度来防止脂溶性配体重新结合的潜在偏差。利用该测定法的时间分辨率,还重新审视了抗精神病药物kon的变异性。kon是根据假设描述结合过程的简单数学模型从实验记录中估算出来的。氟哌啶醇(典型抗精神病药物)的恢复时间进程仅比非典型抗精神病药物氨磺必利、氯氮平和喹硫平慢6.4至2.5倍,而发现抗精神病药物的kon变化范围比先前认为的更广。最后,使用我们估算的kon和koff计算出的亲和力与功能效价以及放射性配体结合研究报告的亲和力密切相关。鉴于这些发现,典型和非典型抗精神病药物主要通过其D2R结合动力学来区分的可能性似乎不大。